Stereoselectivity in the metabolism of the .BETA.-adrenergic blocking agent, (.+-.)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.